Home > Category > Signaling Pathways > Microbiology/Virology/Anti-infection > HIV Protease > Zalcitabine (ddC; Dideoxycytidine; 2',3'-Dideoxycytidine)

Zalcitabine (ddC; Dideoxycytidine; 2',3'-Dideoxycytidine)

ChemLeader 98+%
Catalog No:CL2159 CAS No.:7481-89-2 MDLNo: Formula:C9H13N3O3 MW:211.22
Size Availability Price(USD) VIP Price (USD) Quantity
100 mg In-stock $200.00 Visible after login
- +
250 mg In-stock $320.00 Visible after login
- +
500 mg 3-5days $386.00 Visible after login
- +

Chemical safety data sheet(MSDS)

Download MSDS

Certificate Of Authenticity(CPA)

  • Product Overview
  • Related documents
  • Product details
  • Related literature
Product Overview
Product Name Zalcitabine (ddC; Dideoxycytidine; 2',3'-Dideoxycytidine)
CAS7481-89-2
FormulaC9H13N3O3
MW211.22
AppearanceWhite to light yellow powder
Storage conditionDry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).
Product details

Zalcitabine is a nucleoside analog HIV reverse transcriptase inhibitor (NARTI). It is an antiviral pyrimidine nucleoside analogue effective against HIV replication. 2′,3′-Dideoxycytidine, when activated to its triphosphate, is incorporated into DNA by HIV-1 RT (HIV-1 reverse transcriptase), causing DNA chain termination and viral replication. Zalcitabine was the third antiretroviral to be approved by the Food and Drug Administration (FDA) for the treatment of HIV/AIDS. It is used as part of a combination regimen. Zalcitabine appears less potent than some other nucleoside RTIs, has an inconvenient three-times daily frequency and is associated with serious adverse events. For these reasons it is now rarely used to treat human immunodeficiency virus (HIV), and it has even been removed from pharmacies entirely in some countries.

Related literature
Sorry, there is no relevant literature
Related
Sorry, no related items
Service
ChemLeader
021-58180488
Online service time: 9:00-18:00 on weekdays